Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.60 | 23.28 |
| PEG Ratio (TTM) | -0.15 | 2.69 |
| P/S Ratio (TTM) | 0.37 | 7.32 |
| P/B Ratio (TTM) | 0.21 | 7.44 |
| P/FCF Ratio (TTM) | N/A | 35.21 |
| Price to 5YR AVG Earnings Ratio | 0.29 | 36.33 |
| Price to 5YR AVG FCF Ratio | -0.16 | 45.57 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.65% | 19.59% |
| ROE (TTM) | -3.71% | 28.05% |
| Net Profit Margin (TTM) | -6.53% | 1.29% |
| ROIC 5YR AVG | -14.13% | 24.60% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -43.49% | 338.02% | 217.30% |
| Revenue | 1.35% | -8.22% | -12.06% |
| Net Income | -43.07% | 343.90% | 220.83% |
| Cash Flow | N/A | -99.89% | -67.58% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.86 | 2.39 |
| Quick Ratio (TTM) | 2.85 | 2.39 |
| D/E Ratio (TTM) | 0.04 | 0.04 |
| Interest Coverage (TTM) | N/A | 223.73 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 0.60 | 13.35 |
| LTL to 5YR AVG FCF | -0.22 | 0.51 |
| Shares Outstanding Growth 5YR AVG | 0.29% | -1.35% |